Nirav N. Shah, MD¹, Michael L. Wang, MD², Jennifer R. Brown, MD, PhD³, Krish Patel, MD⁴, Jennifer A. Woyach, MD⁵, William G. Wierda, MD, PhD⁶, Chaitra S. Ujjani, MD⁷, Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD^8*, Pier Luigi Zinzani, MD, PhD⁹, Alvaro J. Alencar, MD¹⁰, Thomas Gastinne, MD^11*, Paolo Ghia, MD, PhD¹², Nicole Lamanna, MD^13,14, Marc Hoffmann, MD¹⁵, Manish R. Patel, MD¹⁶, Ian W. Flinn, MD PhD¹⁷, James N. Gerson, MD¹⁸, Shuo Ma, MD¹⁹, Catherine C. Coombs, MD²⁰, Chan Yoon Y. Cheah, MD²¹, Ewa Lech-Marańda, MD, PhD^22*, Bita Fakhri, MD, MPH²³, Won-Seog Kim^24*, Minal A. Barve, MD^25*, Jonathon B. Cohen, MD, MS²⁶, Wojciech Jurczak, MD, PhD^27*, Talha Munir, MBBS, MRCP, FRCPath, PhD^28*, Meghan C. Thompson, MD²⁹, Lindsey Roeker, MD²⁹, Katherine Bao, PhD^30*, Nicholas A. Cangemi, BS^30*, Jennifer F. Kherani, MD^30*, Richard A. Walgren, MD, PhD³⁰, Hongmei Han, MS^30*, Amy S. Ruppert, PhD^31* and Anthony R. Mato, MD, MSCE²⁹

¹Medical College of Wisconsin, Brookfield, WI
²MD Anderson Cancer Center, Houston, TX
³Chronic Lymphocytic Leukemia Center, Division of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
⁴Swedish Cancer Institute, Center for Blood Disorders and Cellular Therapy, Seattle, WA
⁵Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY
⁶The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁷Fred Hutchinson Cancer Center, University of Washington, Seattle, WA
⁸Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, United Kingdom
⁹Institute of Hematology “Seràgnoli” University of Bologna, Bologna, Italy
¹⁰Miller School of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
¹¹Hematology Department, Nantes University Hospital, Nantes, France
¹²Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy
¹³New York-Presbyterian Columbia University Medical Center, New York, NY
¹⁴New York-Presbyterian/ Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center, New York, NY
¹⁵The University of Kansas Cancer Center, Kansas City, KS
¹⁶Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, FL
¹⁷Sarah Cannon Research Institute, Nashville, TN
¹⁸Lymphoma Program, Abramson Cancer Center, Philadelphia, PA
¹⁹Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL
²⁰Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
²¹Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, WEA, Australia
²²Institute of Hematology and Transfusion Medicine, Warsaw, Poland
²³Division of Hematology and Oncology, University of California, San Francisco, CA
²⁴Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
²⁵Mary Crowley Cancer Research Center, Dallas, TX
²⁶Winship Cancer Institute, Emory University, Atlanta, GA
²⁷Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
²⁸Department of Haematology, St James's University Hospital, Leeds, United Kingdom
²⁹Memorial Sloan Kettering Cancer Center, New York, NY
³⁰Loxo@Lilly, Indianapolis, IN
³¹Eli Lilly and Company, Indianapolis, IN

Emily Bryer, DO¹, Andy Itsara, MD, PhD^1*, Inhye E. Ahn, MD², Beth Kozel, MD, PhD^3*, Cody Peer, PhD^4*, William D. Figg, PhD^4*, Adrian Wiestner, MD¹ and Clare Sun, MD¹

¹Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
²National Institutes of Health Clinical Center, Brookline, MA
³National Institutes of Health, Laboratory of Vascular and Matrix Genetics, National Heart, Lung, and Blood Institute, Bethesda
⁴Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD

Cecilia Bonolo De Campos, PhD^1*, Chantal McCabe, Ph.D.^2*, Laura Ann Bruins, BS^3*, Daniel R. O'Brien^4*, Sochilt Brown^5*, Cristine Allmer^6*, Yuan Xiao Zhu, Ph.D.^1*, Kari G Rabe, MS^7*, Sameer A. Parikh, MD⁸, Neil E. Kay, MD^8,9, James R. Cerhan, MD, PhD¹⁰, Laura Z Rassenti, PhD^11*, Richard R. Furman, MD¹², J. Brice Weinberg, MD¹³, Danielle Brander, MD¹⁴, Marta Chesi, PhD⁵, Susan L. Slager, PhD^4,15 and Esteban Braggio, PhD¹⁶

¹Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ
²Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
³Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ
⁴Division of Computational Biology, Mayo Clinic, Rochester, MN
⁵Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ
⁶Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN
⁷Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN
⁸Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
⁹Department of Immunology, Mayo Clinic, Rochester, MN
¹⁰Division of Epidemiology, Mayo Clinic, Rochester, MN
¹¹Center for Novel Therapeutics, University of California, San Diego, La Jolla, San Diego, CA
¹²Division of Hematology and Oncology, Weill Cornell Medical College, New York, NY
¹³Division of Hematology, VA & Duke Medical Centers, Durham, NC
¹⁴Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC
¹⁵Division of Hematology, Mayo Clinic, Rochester, MN
¹⁶Division of Hematology and Medical Oncology, Mayo Clinic Arizona, Scottsdale, AZ

Mark-David Levin¹, Sabina Kersting, MD, PhD^2*, Julie M.N. Dubois, MD, PhD^3*, Yvette Norden, PhD^4*, Johan A Dobber^5*, Yvonne W.S. Jauw, MD^6*, Anne-Marie van der Kevie-Kersemaekers^7*, Clemens Mellink^8*, Koen de Heer, MD^9*, Leonie van der Burg^10*, Doreen Te Raa^11*, Fransien de Boer^12*, Jolanda Droogendijk, MD^13*, Cecile Idink, MD, PhD^14*, Marten R. Nijziel, MD, PhD¹⁵, Lidwine W. Tick, MD, PhD¹⁶, Inge Ludwig, MD, MSc^17*, Matthijs Silbermann^18*, Aart Beeker¹⁹, Mar Bellido, MD, PhD^20*, Ludo M. Evers^21,22*, Gerben JC Zwezerijnen, MD^23*, Carsten U Niemann, MD^24* and Arnon P. Kater, MD, PhD³

¹Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands
²Department of Hematology, Haga Teaching Hospital, The Hague, Netherlands
³Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
⁴HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
⁵Laboratory of Hematology, Amsterdam University Medical Centers, Amsterdam, Netherlands
⁶Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, NLD
⁷Department of Human Genetics, Academical medical Center, Amsterdam, Netherlands
⁸Department of Human Genetics, Academical Medical Center Amsterdam, Amsterdam, Netherlands
⁹Department of Internal Medicine, Flevohospital, Almere, Netherlands
¹⁰Antonius Hospital Sneek, Sneek, Netherlands
¹¹Gelderland valley hospital, Ede, NLD
¹²Ikazia hospital, Rotterdam, Netherlands
¹³hematology, tweesteden ziekenhuis, Tilburg, NLD
¹⁴Department of Internal Medicine, ZorgSaam Hospital Terneuzen, Terneuzen, Netherlands
¹⁵Catharina Hospital, Eindhoven, NLD
¹⁶Maxima Medical Center, Veldhoven, NLD
¹⁷Department of Hematologie, Bernhoven Hospital, Uden, NLD
¹⁸Ter Gooi Hospital, HILVERSUM, NLD
¹⁹Spaarne Ziekenhuis, Hoofddorp, Netherlands
²⁰Department of Hematology, University Medical Center Groningen, Groningen, Netherlands
²¹Department of Laboratory special hematology, Academical Medical Center Amsterdam, Amsterdam, Netherlands
²²Amsterdam University medical Center, University, Amsterdam, Netherlands
²³Department of Radiology and Nuclear Medicine, Amsterdam UMC, Location VUmc, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands
²⁴Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Ekaterina Kim, PhD, MS^1*, Mariela Sivina, PhD^1*, Alicia Vaca, PhD^1*, Alessandra Ferrajoli¹, Nitin Jain, MD², Philip A. Thompson, MBBS¹, William G. Wierda, MD, PhD¹, Dominik Wodarz, PhD^3*, Nicholas Chiorazzi, MD⁴ and Jan A. Burger, MD, PhD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, MD Anderson Cancer Center, Houston, TX
³University of California Irvine, Irvine, CA
⁴Karches Center for Oncology Research, The Feinstein Institute for Medical Research, Manhasset, NY

William J Archibald, MD¹, Anna Barcellos^2*, Jacob Ambrose^2*, Andrew J. Belli^2*, Laura Fernandes^2*, Eric Hansen^2*, Ching-Kun Wang^2* and Paul M. Barr, MD¹

¹University of Rochester Medical Center, Rochester, NY
²COTA, Inc, New York, NY

Roberta Murru^1*, Andrea Galitzia, MD^2*, Giovanni Caocci, MD³, Luca Barabino, MD^2*, Roberta Presicci^2*, Fabio Culurgioni^4*, Stefania Massidda^5*, Sara Oppi^4* and Giorgio La Nasa, MD^3*

¹Hospital A. Businco, ARNAS “G. Brotzu”, Cagliari, CAGLIARI, Italy
²Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy
³Hematology and Stem Cell Transplantation Unit, Ospedale Oncologico A. Businco, ARNAS G. Brotzu, Cagliari, Italy
⁴Hematology and Stem Cell Transplantation Unit, Ospedale Oncologico A. Businco, AO Brotzu, Cagliari, Italy
⁵Ospedale Oncologico "A. Businco", Struttura Complessa di Ematologia e Centro Trapianti Cellule Staminali Emopoietiche, Cagliari, Italy

Tiffany Seto, MD¹, Kelli Peterman, MPH^2*, Deepika Kumar, MD^1*, Jonathan Zaroff, MD^1*, David M. Baer, MD³, Diane M. Carpenter, MPH^4* and Alfredo R. Lopez, MD¹

¹Kaiser Permanente, San Francisco, CA
²Kaiser Permanente, Oakland, CA
³Hematology Oncology, Kaiser Permanente, Oakland, Oakland, CA
⁴Division of Research, Kaiser Permanente, Oakland, CA

Rayan Ramadan^1,2*, Alaa Alzaki, MBBS, FRCPC, ABIM^3* and Heather A. Leitch, MD, PhD⁴

¹Division of Hematology, St Paul’s Hospital and the University of British Columbia, Maple Ridge, BC, Canada
²St. Paul's Hospital, Maple Ridge, BC, Canada
³Division of Hematology, St Paul’s Hospital and the University of British Columbia, Vancouver, BC, Canada
⁴St. Paul's Hospital University of British Columbia, Vancouver, BC, Canada

Kevin H. Lin, MD, PhD^1*, Lynn Huynh^2*, Xiaoqin Yang, PhD^3*, Neema Lema, BA^4*, Lisa Matay, BA^5*, Sobana Balasubramanian, BA^1*, Daria Liborski, BS^1*, Mikaela M. McDonough, BS^1*, Jillian Foreman, BS^1*, Mohammed Z.H. Farooqui, DO³, Enrico De Nigris, MSc^6*, Shravanthi R. Gandra, PhD, MBA^3*, Eric Sarpong, PhD^3*, Mei Sheng Duh, ScD, MPH², Jennifer R. Brown, MD, PhD⁷ and Matthew S. Davids, MD¹

¹Dana-Farber Cancer Institute, Boston, MA
²Analysis Group, Inc., Boston, MA
³Merck & Co., Inc., Kenilworth, NJ
⁴Analysis Group, Inc., Menlo Park, CA
⁵Analysis Group, Inc., San Francisco, CA
⁶Merck & Co., Inc., Barnsbury, United Kingdom
⁷Department of Medical Oncology, Dana-Farber Cancer Institute, Newton, MA

Adam J DiPippo, PharmD^1*, Alicia McGhie^1*, Jenessa Lee^1*, Philip A. Thompson, MBBS², Nitin Jain, MD³, William G. Wierda, MD, PhD⁴, Hagop Kantarjian, MD⁵ and Alessandra Ferrajoli⁶

¹Department of Clinical Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁴The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX

Lindsey Roeker, MD¹, Maral DerSarkissian, PhD^2*, Kellie J. Ryan, MPH^3*, Yan Chen^4*, Svea K. Wahlstrom, VMD, MS^5*, Shweta Hakre, PhD⁶, Louise Yu, MSc^2*, Helen Guo, BA^4* and Anthony R. Mato, MD, MSCE¹

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Analysis Group, Inc., Boston, MA
³Global Medical Affairs, AstraZeneca Pharmaceuticals, Gaithersburg, MD
⁴Analysis Group, Boston, MA
⁵US Patient Safety Surveillance, AstraZeneca Pharmaceuticals, Wilmington, DE
⁶US Medical Affairs, AstraZeneca Pharmaceuticals, Gaithersburg, MD

Paolo Ghia, MD, PhD¹, Carolyn Owen, MD², Jacqueline C. Barrientos, MD, MS³, Paul M. Barr, MD⁴, Anthony R. Mato, MD, MSCE⁵, Chunxue Shi, MSc^6*, Anita Szoke, MD^7*, Chris Abbazio, PharmD^7*, Gabriel S. Krigsfeld, PhD^7* and Jan A. Burger, MD, PhD⁸

¹Division of Experimental Oncology, Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy
²Tom Baker Cancer Centre, University of Calgary and Alberta Health Services, Calgary, AB, Canada
³Columbia University Division of Hematology/Oncology, Mount Sinai Medical Center, Miami, FL
⁴Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
⁵Chronic Lymphocytic Leukemia Program, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Everest Clinical Research, Owings Mills, MD
⁷Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA
⁸Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

William Townsend^1*, Sarah Leong, MBBS^2*, David Tucker, MD^3*, Bryson Pottinger^4*, Shankara Paneesha, MD⁵, Dima El-Sharkawi, MBBS, FRCPath, PhD^6*, Toby A. Eyre, MBBChir, MRCP^7*, Toby Batten^8*, Mittal Shah, PhD^9*, Sarah Cook^9*, David Granger, PhD^10*, Kieran O'Donovan, PhD^11*, Amit C. Nathwani, MD, PhD^11,12 and Parag Jasani, FRCPath, MBBS, MRCP^13,14*

¹National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust and UCLH, London, United Kingdom
²NIHR Clinical Research Facility, University College London Hospitals, London, GBR
³Royal Cornwall Hospital, Cornwall, United Kingdom
⁴Dep. of Haematology, Royal Cornwall Hospital, Truro, United Kingdom
⁵Birmingham Heartlands Hospital, Birmingham, United Kingdom
⁶The Royal Marsden NHS Foundation Trust, Surrey, United Kingdom
⁷Department of Haematology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, HP11 2TJ, United Kingdom
⁸Veramed, Twickenham, ENG, GBR
⁹NovalGen Ltd, London, ENG, United Kingdom
¹⁰NovalGen Ltd, London, GBR
¹¹NovalGen Ltd, London, United Kingdom
¹²Katharine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free NHS Foundation Trust, London, United Kingdom
¹³NIHR Clinical Research Facility, University College London Hospitals, London, United Kingdom
¹⁴Royal Free London NHS Foundation Trust, London, United Kingdom

Huayuan Zhu^1,2,3*, Yeqin Sha^1,2,3*, Yi Miao^1,2,3*, Shuchao Qin^1,2,3, Hui Shen^1,2,3*, Jingyan Qiu^1,2,3*, Wei Wu^1,2,3*, Yi Xia^1,2,3*, Tonglu Qiu^1,2,3*, Li Wang^1,2,3*, Lei Fan^1,2,3*, Wei Xu^1,2,3 and Jianyong Li, MD^1,2,3

¹Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
²Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China
³Pukou CLL Center, Pukou division of Jiangsu Province Hospital, Nanjing, China

Isaac Esplin^1*, Ying Huang, MS, MA^2*, Seema A. Bhat, MD^3,4, Cara Grantier, CNP, MPH, MS^5*, Michael R. Grever, MD^3,6, Corinne Hoffman, MS, CNP^3*, Adam S Kittai, MD^3,7, Margaret S. Lucas, PA-C^8*, Mollie E. Moran^9*, Mark Reid, CNP^3*, Swetha Suresh, APRN-CNP^10*, Jennifer A. Woyach, MD^11,12 and Kerry A. Rogers, MD^2,3

¹The Ohio State University College of Medicine, Columbus, OH
²Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
³The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁴Division of Hematology, The Ohio State University, Columbus, OH
⁵The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Division of Hematology, Columbus, OH
⁶Department of Internal Medicine, Division of Hematology, Wexner Medical Center at Ohio State University, Columbus, OH
⁷Division of Hematology, The Ohio State University, COLUMBUS, OH
⁸Ohio State University Comprehensive Cancer Center, The Ohio state University, Columbu, OH
⁹Ohio State Comprehensive Cancer Center, The Ohio State University, Columbus, OH
¹⁰Ohio State University Comprehensive Cancer Center, The Ohio state University, Columbus, OH
¹¹Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY
¹²Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH

Andy Itsara, MD, PhD^1*, Clare Sun, MD¹, Inhye E. Ahn, MD², Susan Soto, RN, MSN^1*, Douglas Rosing, MD^3*, Mark Haigney, MD^4* and Adrian Wiestner, MD, PhD¹

¹Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
²Dana-Farber Cancer Institute, Boston, MA
³Cardiovascular Branch, National Institutes of Health, National Heart, Lung and Blood Institute, Bethesda, MD
⁴Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD

Clive S. Zent, MD¹, Jeremiah E. Moore, PharmD^2*, Paige C. Bloom, NP^2*, Charles C. Chu, PhD¹, Jennifer E. Bruno, BS^3*, Christine A. Herne, PhD^1*, Andrea M Baran, MS^4*, Sally A. Quataert, PhD^3*, Tim R. Mosmann, PhD^3*, Ronald P. Taylor, PhD^5*, Danielle S. Wallace, MD², Michael R. Elliott, PhD^6* and Paul M. Barr, MD¹

¹Wilmot Cancer Institute, Department of Medicine, University of Rochester Medical Center, Rochester, NY
²Wilmot Cancer Institute, Division of Hematology/Oncology, University of Rochester Medical Center, Rochester, NY
³Department of Microbiology and Immunology, Center for Vaccine Biology & Immunology, and Human Immunology Center, University of Rochester Medical Center, Rochester, NY
⁴Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY
⁵University of Virginia, Charlottesville, VA
⁶Center for Cell Clearance and the Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA

Matthew S. Davids, MD¹, Jeff P. Sharman, MD², Toby A. Eyre, MBBChir, MRCP^3*, Jennifer A. Woyach, MD⁴, Paulo Andre P. de Miranda, MD⁵, Mina Shahkarami^6*, Anna Butturini^6*, Ugochinyere Emeribe^5* and John C. Byrd, MD⁷

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Willamette Valley Cancer Institute and Research Center/US Oncology Research, Eugene, OR
³Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
⁴Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY
⁵AstraZeneca, Gaithersburg, MD
⁶AstraZeneca, South San Francisco, CA
⁷University of Cincinnati College of Medicine, Cincinnati, OH

Chenyu Lin, MD^1,2, Micaela R. Scobie, PhD^1,3*, Daphne R. Friedman, MD^1,2, Michael J. Kelley, MD^1,2,3* and Thomas D. Rodgers, MD^1,2

¹Durham VA Medical Center, Durham, NC
²Duke University School of Medicine, Durham, NC
³U.S. Dept of Veteran Affairs National Precision Oncology Program, Durham, NC

Stefano Molica, MD¹, Potito Rosario Scalzulli, MD^2*, Lydia Scarfo, MD^3*, Attilio Guarini, MD^4*, Roberta Murru^5*, Paolo Sportoletti, MD^6*, Ferdinando Frigeri^7*, Francesco Albano, MD^8,9*, Nicola Di Renzo, MD^10*, Alessandro Sanna, MD^11*, Idanna Innocenti, PhD^12*, Massimo Massaia, MD¹³, Marta Coscia^14*, Elsa Pennese, MD^15*, Caterina Patti^16*, Gianluigi Reda, MD^17*, Agostino Tafuri¹⁸, Giulia Regazzoni^19*, Michele Di Candia^19* and Francesca Romana Mauro, MD^20*

¹Department Hematology-Oncology- Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro,Italy, Catanzaro, Italy
²Hematology, "Casa Sollievo della Sofferenza" Hospital IRCCS, S. Giovanni Rotondo (FG), Italy
³San Raffaele Hospital and Università Vita-Salute San Raffaele, Milan, Italy
⁴Hematology and Cell Therapy Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy
⁵Hospital A. Businco, ARNAS “G. Brotzu”, Cagliari, CAGLIARI, Italy
⁶Department of Medicine, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy
⁷Hematology Unit, Ospedale of Caserta, Italy, Caserta, Italy
⁸Department of Emergency and Organ Transplantation - University of Bari "Aldo Moro", Bari, Italy
⁹University of Bari, Department of Emergency and Organ Transplantation (D.E.T.O.), Hematology Section, Bari, Italy
¹⁰"Vito Fazzi" Hospital, Lecce, Italy
¹¹Department of Hematology, AOU Careggi - University of Florence, Florence, Italy
¹²Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
¹³Division of Hematology, AO S.Croce e Carle, Cuneo, Italy, Torino, Italy
¹⁴Division of Hematology, A.O.U. Cittàdella Salute e dellaScienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy
¹⁵U.O.S.D. Centro Diagnosi e Terapia dei Linfomi, Dipartimento Oncologico-Ematologico, Presidio Ospedaliero "Spirito Santo", Pescara, Italy
¹⁶Division of Onco-Hematology, Azienda Villa Sofia Cervello, Palermo, Italy
¹⁷Hematology unit, Hematology Unit, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico of Milan, Milan, Italy
¹⁸University Hospital Sant'Andrea-Sapienza, Rome, Italy
¹⁹Medical Affairs Hematology - Janssen, Milano, Italy
²⁰Hematology, Department of Translational and Precision Medicine, Sapienza University, Policlinico Umberto I, Roma, Italy